Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Macrophage-derived LTB4 promotes abscess formation and clearance of Staphylococcus aureus skin infection in mice.

Tytuł:
Macrophage-derived LTB4 promotes abscess formation and clearance of Staphylococcus aureus skin infection in mice.
Autorzy:
Brandt SL; Indiana University School of Medicine, Department of Microbiology & Immunology, Indianapolis, Indiana, United States of America.; Vanderbilt University Medical Center, Department of Medicine, Division of Infectious Disease, Nashville, Tennessee, United States of America.
Klopfenstein N; Vanderbilt University Medical Center, Department of Medicine, Division of Infectious Disease, Nashville, Tennessee, United States of America.; Vanderbilt University Medical Center, Department of Pathology, Microbiology and Immunology, Nashville, Tennessee, United States of America.
Wang S; Indiana University School of Medicine, Department of Microbiology & Immunology, Indianapolis, Indiana, United States of America.
Winfree S; Indiana Center for Biological Microscopy, Indianapolis, Indiana, United States of America.
McCarthy BP; Indiana Institute for Biomedical Imaging Sciences, Department of Radiology, Indianapolis, Indiana, United States of America.
Territo PR; Indiana Institute for Biomedical Imaging Sciences, Department of Radiology, Indianapolis, Indiana, United States of America.
Miller L; Johns Hopkins University School of Medicine, Department of Dermatology, Baltimore, Maryland, United States of America.
Serezani CH; Indiana University School of Medicine, Department of Microbiology & Immunology, Indianapolis, Indiana, United States of America.; Vanderbilt University Medical Center, Department of Medicine, Division of Infectious Disease, Nashville, Tennessee, United States of America.; Vanderbilt University Medical Center, Department of Pathology, Microbiology and Immunology, Nashville, Tennessee, United States of America.; Vanderbilt Institute of Infection, Immunology and Inflammation, Nashville, Tennessee, United States of America.
Źródło:
PLoS pathogens [PLoS Pathog] 2018 Aug 13; Vol. 14 (8), pp. e1007244. Date of Electronic Publication: 2018 Aug 13 (Print Publication: 2018).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
Język:
English
Imprint Name(s):
Original Publication: San Francisco, CA : Public Library of Science, c2005-
MeSH Terms:
Methicillin-Resistant Staphylococcus aureus*/growth & development
Methicillin-Resistant Staphylococcus aureus*/immunology
Abscess/*immunology
Bacterial Load/*immunology
Leukotriene B4/*physiology
Macrophages/*metabolism
Staphylococcal Skin Infections/*immunology
Abscess/genetics ; Abscess/microbiology ; Abscess/pathology ; Animals ; Arachidonate 5-Lipoxygenase/genetics ; Bacterial Load/genetics ; Cells, Cultured ; Female ; Leukotriene B4/metabolism ; Macrophages/immunology ; Male ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Receptors, Leukotriene B4/genetics ; Staphylococcal Skin Infections/genetics ; Staphylococcal Skin Infections/pathology
References:
FASEB J. 2009 Oct;23(10):3393-404. (PMID: 19525403)
J Clin Invest. 2011 Feb;121(2):671-82. (PMID: 21206089)
Infect Immun. 1998 Nov;66(11):5140-6. (PMID: 9784515)
N Engl J Med. 2007 Nov 1;357(18):1841-54. (PMID: 17978293)
Shock. 2004 Dec;22(6):513-20. (PMID: 15545821)
Prim Care. 2015 Dec;42(4):485-99. (PMID: 26612370)
Diabetes. 2016 Dec;65(12):3718-3729. (PMID: 27605625)
J Biol Chem. 2011 Aug 19;286(33):28902-13. (PMID: 21715328)
Semin Immunopathol. 2012 Mar;34(2):261-80. (PMID: 22057887)
Blood. 2009 Oct 8;114(15):3316-24. (PMID: 19657115)
Immunity. 2012 Oct 19;37(4):747-58. (PMID: 23063331)
J Leukoc Biol. 2012 Feb;91(2):207-15. (PMID: 22058421)
Dev Cell. 2012 May 15;22(5):1079-91. (PMID: 22542839)
Clin Exp Dermatol. 2000 Jul;25(5):423-31. (PMID: 11012601)
J Exp Med. 2013 Sep 23;210(10):2025-39. (PMID: 24043764)
Trends Pharmacol Sci. 2017 May;38(5):473-488. (PMID: 28283200)
Wiley Interdiscip Rev Syst Biol Med. 2009 Nov-Dec;1(3):309-333. (PMID: 20836000)
Immunity. 2006 Jan;24(1):79-91. (PMID: 16413925)
J Innate Immun. 2014;6(5):619-31. (PMID: 24820433)
Free Radic Biol Med. 2012 Jul 1;53(1):72-80. (PMID: 22583699)
Hum Reprod. 1996 Sep;11(9):1952-7. (PMID: 8921070)
Ann Plast Surg. 2011 Dec;67(6):632-6. (PMID: 21407055)
J Immunol. 2014 Mar 1;192(5):2349-56. (PMID: 24477912)
J Immunol. 2013 Feb 15;190(4):1614-22. (PMID: 23325886)
Trends Microbiol. 2011 May;19(5):225-32. (PMID: 21353779)
J Invest Dermatol. 2010 Jul;130(7):1866-76. (PMID: 20182449)
Sci Signal. 2015 Jan 27;8(361):ra10. (PMID: 25628460)
J Immunol. 2015 Mar 15;194(6):2735-45. (PMID: 25681348)
Cell Microbiol. 2013 Jun;15(6):891-909. (PMID: 23217115)
PLoS One. 2012;7(3):e31701. (PMID: 22448213)
Ann Dermatol Venereol. 2002 Jan;129(1 Pt 1):27-9. (PMID: 11937926)
J Biol Chem. 1991 Jan 25;266(3):1375-8. (PMID: 1846352)
J Innate Immun. 2014;6(2):159-68. (PMID: 23988515)
Am J Respir Cell Mol Biol. 1994 Jul;11(1):95-102. (PMID: 8018341)
Eur J Clin Microbiol Infect Dis. 2004 Dec;23(12):909-11. (PMID: 15599653)
Arch Immunol Ther Exp (Warsz). 2015 Apr;63(2):109-15. (PMID: 25182982)
J Immunol. 2007 Jun 15;178(12):8036-45. (PMID: 17548641)
JCI Insight. 2017 Jul 6;2(13):null. (PMID: 28679957)
Am J Respir Crit Care Med. 1997 May;155(5):1789-92. (PMID: 9154893)
Infect Control Hosp Epidemiol. 2010 Aug;31(8):838-41. (PMID: 20569116)
Nature. 2013 Jun 20;498(7454):371-5. (PMID: 23708969)
Nat Rev Immunol. 2013 Mar;13(3):159-75. (PMID: 23435331)
J Immunol. 2012 Jul 15;189(2):906-15. (PMID: 22696442)
Infect Immun. 2010 May;78(5):2264-71. (PMID: 20231413)
Nat Rev Immunol. 2011 Jul 01;11(8):505-18. (PMID: 21720387)
J Immunol. 2006 Sep 1;177(5):3201-8. (PMID: 16920959)
J Infect Chemother. 2011 Dec;17(6):851-4. (PMID: 21534001)
J Clin Invest. 1989 Nov;84(5):1609-19. (PMID: 2553777)
Blood. 2000 Jul 15;96(2):719-26. (PMID: 10887140)
J Invest Dermatol. 2010 Jun;130(6):1571-80. (PMID: 20147964)
J Immunol. 1996 Dec 15;157(12):5221-4. (PMID: 8955165)
Blood. 2005 Aug 1;106(3):1067-75. (PMID: 15718414)
Nature. 1994 Nov 10;372(6502):179-82. (PMID: 7969451)
CJEM. 2007 Jul;9(4):300-3. (PMID: 17626697)
Am J Pathol. 2015 Jun;185(6):1518-27. (PMID: 25749135)
Transl Res. 2012 Oct;160(4):246-57. (PMID: 22683238)
Prostaglandins. 1993 Jun;45(6):527-34. (PMID: 8393205)
Nat Immunol. 2003 Oct;4(10):982-90. (PMID: 12949531)
Grant Information:
S10 OD021804 United States OD NIH HHS; R01 HL124159 United States HL NHLBI NIH HHS; R01 AR069502 United States AR NIAMS NIH HHS; T32 AI060519 United States AI NIAID NIH HHS; R00 HL103777 United States HL NHLBI NIH HHS; K99 HL103777 United States HL NHLBI NIH HHS
Substance Nomenclature:
0 (Ltb4r1 protein, mouse)
0 (Receptors, Leukotriene B4)
1HGW4DR56D (Leukotriene B4)
EC 1.13.11.34 (Arachidonate 5-Lipoxygenase)
Entry Date(s):
Date Created: 20180814 Date Completed: 20190122 Latest Revision: 20240312
Update Code:
20240312
PubMed Central ID:
PMC6107286
DOI:
10.1371/journal.ppat.1007244
PMID:
30102746
Czasopismo naukowe
The early events that shape the innate immune response to restrain pathogens during skin infections remain elusive. Methicillin-resistant Staphylococcus aureus (MRSA) infection engages phagocyte chemotaxis, abscess formation, and microbial clearance. Upon infection, neutrophils and monocytes find a gradient of chemoattractants that influence both phagocyte direction and microbial clearance. The bioactive lipid leukotriene B4 (LTB4) is quickly (seconds to minutes) produced by 5-lipoxygenase (5-LO) and signals through the G protein-coupled receptors LTB4R1 (BLT1) or BLT2 in phagocytes and structural cells. Although it is known that LTB4 enhances antimicrobial effector functions in vitro, whether prompt LTB4 production is required for bacterial clearance and development of an inflammatory milieu necessary for abscess formation to restrain pathogen dissemination is unknown. We found that LTB4 is produced in areas near the abscess and BLT1 deficient mice are unable to form an abscess, elicit neutrophil chemotaxis, generation of neutrophil and monocyte chemokines, as well as reactive oxygen species-dependent bacterial clearance. We also found that an ointment containing LTB4 synergizes with antibiotics to eliminate MRSA potently. Here, we uncovered a heretofore unknown role of macrophage-derived LTB4 in orchestrating the chemoattractant gradient required for abscess formation, while amplifying antimicrobial effector functions.
Competing Interests: The authors have declared that no competing interests exist.
Comment in: Nat Chem Biol. 2018 Oct;14(10):903. (PMID: 30224689)
Zaloguj się, aby uzyskać dostęp do pełnego tekstu.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies